Exicure, Inc. (XCUR)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
Oct 02, 16:00
1.16
+0.01
(+0.87%)
After-Hours: 20:00
Exicure Enterprise Value : 5.613M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.613M |
| October 01, 2026 | 5.804M |
| September 30, 2026 | 5.867M |
| September 29, 2026 | 5.549M |
| September 28, 2026 | 6.155M |
| September 25, 2026 | 6.059M |
| September 24, 2026 | 6.123M |
| September 23, 2026 | 6.187M |
| September 22, 2026 | 6.505M |
| September 21, 2026 | 6.314M |
| September 18, 2026 | 6.123M |
| September 17, 2026 | 6.888M |
| September 16, 2026 | 6.760M |
| September 15, 2026 | 6.633M |
| September 14, 2026 | 7.015M |
| September 11, 2026 | 7.206M |
| September 10, 2026 | 7.015M |
| September 09, 2026 | 7.398M |
| September 08, 2026 | 7.270M |
| September 04, 2026 | 6.250M |
| September 03, 2026 | 6.123M |
| September 02, 2026 | 6.505M |
| September 01, 2026 | 6.569M |
| August 31, 2026 | 6.633M |
| August 28, 2026 | 6.505M |
| Date | Value |
|---|---|
| August 27, 2026 | 7.270M |
| August 26, 2026 | 6.314M |
| August 25, 2026 | 5.868M |
| August 24, 2026 | 5.613M |
| August 21, 2026 | 5.613M |
| August 20, 2026 | 6.569M |
| August 19, 2026 | 7.525M |
| August 18, 2026 | 7.398M |
| August 17, 2026 | 7.079M |
| August 14, 2026 | 6.250M |
| August 13, 2026 | 6.633M |
| August 12, 2026 | 6.569M |
| August 11, 2026 | 7.206M |
| August 10, 2026 | 7.015M |
| August 07, 2026 | 6.856M |
| August 06, 2026 | 6.888M |
| August 05, 2026 | 7.908M |
| August 04, 2026 | 8.099M |
| August 03, 2026 | 8.354M |
| July 31, 2026 | 8.481M |
| July 30, 2026 | 8.29M |
| July 29, 2026 | 9.310M |
| July 28, 2026 | 9.374M |
| July 27, 2026 | 9.437M |
| July 24, 2026 | 9.501M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -54.72M |
| Century Therapeutics, Inc. | 195.19M |
| Absci Corp. | 1.702B |
| Celularity, Inc. | 114.40M |
| Cardio Diagnostics Holdings, Inc. | 0.5836M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.121M |
| Total Expenses (Quarterly) | 1.121M |
| EPS Diluted (Quarterly) | -0.1759 |
| Earnings Yield | -113.3% |
| Normalized Earnings Yield | -100.45 |